Amoy Diagnostics Co., Ltd. (SHE:300685)
China flag China · Delayed Price · Currency is CNY
18.76
+0.55 (3.02%)
Sep 21, 2026, 3:04 PM CST

Amoy Diagnostics Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,1691,1871,1041,034832.43908.12
Other Revenue
8.6210.394.649.999.758.91
1,1781,1981,1091,044842.18917.03
Revenue Growth
2.83%8.01%6.27%23.91%-8.16%25.90%
Cost of Revenue
216.12219.19181.34176.92153.44147.19
Gross Profit
961.62978.54927.61866.58688.74769.84
Selling, General & Admin
369.15396.29418.83384.71360.44364.31
Research & Development
178.24177.59216.11203.22174.53156.12
Other Operating Expenses
14.9511.44.664.073.144.18
Operating Expenses
567.37592.86650.35597.12545.1534.79
Operating Income
394.25385.68277.25269.46143.64235.05
Interest Expense
-2.99-1.93-1.34-1.2-0.99-0.38
Interest & Investment Income
37.7439.7626.5819.176.115.59
Currency Exchange Gain (Loss)
-48.69-6.852.428.2525.32-9.48
Other Non Operating Income (Expenses)
-17.65-19.08-18.45-0.33-2.08-0.48
EBT Excluding Unusual Items
362.67397.58286.46295.35171.99230.3
Gain (Loss) on Sale of Investments
0.010.71-8.71-15.691.985.85
Gain (Loss) on Sale of Assets
0.540.49-1.06-0.9694.58-1.96
Asset Writedown
-3.54-2.84-0.06-0.04-0.61-0.27
Other Unusual Items
18.4114.9913.2616.1918.1518.06
Pretax Income
378.09410.92289.88294.86286.08251.98
Income Tax Expense
39.7549.6735.0233.3721.7912.95
Earnings From Continuing Operations
338.34361.26254.86261.48264.29239.02
Minority Interest in Earnings
-----0.550.55
Net Income
338.34361.26254.86261.48263.74239.57
Net Income to Common
338.34361.26254.86261.48263.74239.57
Net Income Growth
12.76%41.74%-2.53%-0.86%10.09%32.86%
Shares Outstanding (Basic)
398397398396394399
Shares Outstanding (Diluted)
402401398396394399
Shares Change
1.75%0.80%0.51%0.65%-1.41%-0.36%
EPS (Basic)
0.850.910.640.660.670.60
EPS (Diluted)
0.840.900.640.660.670.60
EPS Growth
10.83%40.63%-3.03%-1.49%11.67%33.33%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
328.46294.6301.64253.8570.7593.61
Free Cash Flow Per Share
0.820.730.760.640.180.23
Dividend Per Share
0.4500.4500.3000.1500.1400.128
Dividend Growth
50.00%50.00%100.00%7.14%9.55%-7.99%
Gross Margin
81.65%81.70%83.65%83.05%81.78%83.95%
Operating Margin
33.48%32.20%25.00%25.82%17.06%25.63%
Profit Margin
28.73%30.16%22.98%25.06%31.32%26.13%
Free Cash Flow Margin
27.89%24.60%27.20%24.33%8.40%10.21%
EBITDA
432.82429.88329.31322.24191.46271.49
EBITDA Margin
36.75%35.89%29.70%30.88%22.73%29.61%
D&A For EBITDA
38.5744.252.0552.7847.8236.45
EBIT
394.25385.68277.25269.46143.64235.05
EBIT Margin
33.48%32.20%25.00%25.82%17.06%25.63%
Effective Tax Rate
10.51%12.09%12.08%11.32%7.62%5.14%
Revenue as Reported
1,1781,1981,1091,044842.18917.03